Society For Risk Analysis Annual Meeting 2017
Session Schedule & Abstracts
* Disclaimer: All presentations represent the views of the authors, and not the organizations that support their research. Please apply the standard disclaimer that any opinions, findings, and conclusions or recommendations in abstracts, posters, and presentations at the meeting are those of the authors and do not necessarily reflect the views of any other organization or agency. Meeting attendees and authors should be aware that this disclaimer is intended to apply to all abstracts contained in this document. Authors who wish to emphasize this disclaimer should do so in their presentation or poster. In an effort to make the abstracts as concise as possible and easy for meeting participants to read, the abstracts have been formatted such that they exclude references to papers, affiliations, and/or funding sources. Authors who wish to provide attendees with this information should do so in their presentation or poster.
|Chair(s): Bernard Goldstein firstname.lastname@example.org
Sponsored by Risk Policy and Law Specialty Group
|Recent activities by both Congress and by EPA Administrator Pruitt provide an opportunity to evaluate approaches for organizing risk-related scientific advisory processes for regulatory agencies. The EPA Science Advisory Board Reform Act has been passed by the US House of Representatives and is awaiting action in the US Senate, which may or may or may not be forthcoming. These have generated media interest and controversy and some have characterized these actions as unnecessarily politicizing science and decreasing the likelihood of the involvement of knowledgeable academic scientists in EPA review processes. Others have pointed out that there is a need to broaden scientific representation in diverse fields, and to improve procedures for balancing perspectives and perceived biases on EPA scientific advisory panels. The Roundtable participants will be asked to focus on the underlying principles that should guide the science advisory processes for the optimal provision of scientific advice on risk-related issues to a regulatory agency. |
Speakers: J Arvai, N Beck, RA Denison, BD Goldstein, KW White, T Yosie
[back to schedule]